A Schedule 13G was
Filed with the SEC on · accession 0002012383-26-003871
JBIO filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 27, 2026. A Schedule 13G was filed regarding Jade Biosciences, Inc. (JBIO), indicating a passive ownership position by an institutional or other holder. The stock moved +1.7% by the first close after the filing.
A Schedule 13G was filed regarding Jade Biosciences, Inc. (JBIO), indicating a passive ownership position by an institutional or other holder. The filing directory contains only index and XML documents without substantive ownership details.
Close before
$14.50
Oct 26, 2026
First close after
+1.66%
$14.74
5 trading days
-3.93%
$13.93
Since filing
+3.93%
$15.07
✦ Ask GOAX AI about this filing — what it means for JBIO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for JBIO?
Click hereJBIO filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Jade Biosciences, Inc. (JBIO), indicating a passive ownership position by an institutional or other holder. The filing directory contains only index and XML documents without substantive ownership details.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
JBIO closed at $14.50 before the filing and $14.74 on Oct 27, 2026 (+1.66%). Five trading days later: $13.93 (-3.93%).
Get alerts when JBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days